FDA Aims To Expand Role Of Digital Health Tech As Part Of PDUFA

By Beth Wang / February 25, 2022 at 10:51 AM
FDA hopes to lay the groundwork to expand the role of digital health technologies in drug development and reviews and increase reliance on decentralized trials as part of the seventh iteration of the prescription drug user fee agreements. House lawmakers have expressed support for the agency’s plans, while also touting legislation they think could help boost the efforts. Digital health technologies can help with conducting decentralized trials in which some or all trial-related procedures and data collection take place at...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.